A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatibility complex class II binding and superantigenic activity (Q71825805)
Jump to navigation
Jump to search
scientific article published on 01 December 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatibility complex class II binding and superantigenic activity |
scientific article published on 01 December 1996 |
Statements
A mutation at glycine residue 31 of toxic shock syndrome toxin-1 defines a functional site critical for major histocompatibility complex class II binding and superantigenic activity (English)
W W Kum
1 December 1996